Join
Live feed
·
INSIDERFilingvia Quantisnow
Crescent Biopharma Inc. logo

Chief Business Officer Doughty Christopher Grant was granted 22,714 units of Ordinary Shares, increasing direct ownership by 58% to 62,194 units (SEC Form 4)

ByQuantisnow·Wall Street's wire, on your screen.
CBIO· Crescent Biopharma Inc.
Health Care
Original source

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track CBIO (Crescent Biopharma Inc.) and more on Quantisnow.